Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial

Aim: To verify the superiority of pemafibrate over placebo and the non-inferiority of pemafibrate to the maximum dose of fenofibrate for determining the percent change in fasting serum triglyceride (TG) levels and to investigate safety by assessing the incidence of adverse events (AEs) and adverse d...

Descripción completa

Detalles Bibliográficos
Autores principales: Arai, Hidenori, Yamashita, Shizuya, Yokote, Koutaro, Araki, Eiichi, Suganami, Hideki, Ishibashi, Shun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005227/
https://www.ncbi.nlm.nih.gov/pubmed/29628483
http://dx.doi.org/10.5551/jat.44412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005227/
https://www.ncbi.nlm.nih.gov/pubmed/29628483
http://dx.doi.org/10.5551/jat.44412

Ejemplares similares